SpeechPathology.com Phone: 800-242-5183

New master brand. Same great company. Introducing continued! Read Our Story

ATX Learning - Difference

Treatment for Epiglottic Inversion

George Charpied, M.S.,CCC-SLP

February 19, 2007

Share:

Question

What exercises can I use with a patient who presents with a moderate dysphagia due to epiglottic inversion secondary to Guillian-Bare syndrome?

Answer

There are several issues that must be addressed before getting to the question of therapeutic intervention. These are the phenomenon of epiglottic activity during swallow, the impairments to be expected from Guillane-Barre' syndrome (GBS), and what the literature says about therapeutic intervention for individuals with GBS related swallowing impairments.

Regarding the phenomenon of epiglottic inversion, Curtis and Sepulveda (1968), consider epiglottic movement, what they call tilt, to be a neuromuscular event, in that there are extrinsic muscles, the geniohyoid and thyrohyoid, innervated by the Trigeminal cranial nerve (CNV) and Ansa Cervicalis, and intrinsic muscles, the thyroepiglotticus and aryepiglotticus, innervated by the Vagus cranial nerve (CNX). Impairment of epiglottic tilt, however, can be due to restrictive (masses or tissue changes) and neuromuscular reasons. It is also best to keep in mind that there is a passive element to epiglottic activity during swallow. This 'trap door-like' activity is do to the epiglottis being approximated to the laryngeal additus by the back and downward movement of the tongue base and up and forward elevation of laryngeal excursion.

Regarding GBS, an acute immune polyneuropathy, is known to be a virally based ascending and descending paralytic disease with neuromuscular manifestations and is thought to be the result of immune sensitization to components of myelin. Primarily transient nature, GBS can have permanent manifestations in 5-10% of patients (Leech and Shuman, 1992). Peripheral nerve involvement can be unilateral or bilateral.

Regarding the swallowing manifestations of GBS, it has been shown the larynx is positioned lower and that the width of the pharynx is maximally expanded in affected subjects. Also, tongue base movement and laryngeal elevation are not the same in GBS subjects. Further, there appears to be a consensus (Leonard, et al., 2004, Pearlman, et al., 1992, IA, Bleier, et al, 2006, Daniels and Foundas, 2001, and Smith, et al., 2000) that epiglottic dysmotility can result from several factors, with neuromuscular impairment being one of them. For example incomplete epiglottic close may be due to a primary oral impairment, pharyngeal motility variability, respiratory support impairments, autonomic nervous system impairments, or even aging. So, when diagnosing patient swallowing with GBS these factors must be taken into account.

In all likelihood, then, epiglottic inversion may be more the result of impaired neuromuscular oral and pharyngeal events surrounding epiglottic movements during swallowing. Hence, any focused intervention on epiglottic inversion will not be as effective as would work with the patient on improving oral and pharyngeal function. Medical literature appears to indicate that between five weeks to three months after onset of GBS symptoms is required before any swallowing therapy be initiated, depending on initial severity and residual fatigue (Peake, et al., 2003). Of course aspiration is a chief concern in this case. Kulemeier, et al. (2000) suggest that utilizing thin, thick, and ultrathick liquids and delivery by cup and spoon during a video fluoroscopic swallowing study of a patient with mild or moderate dysphagia can increase the chances of identifying a consistency that the patient can swallow without aspirating and without pharyngeal retention after swallowing. Once it is established that the patient has a modicum of control over the airway, including sufficient tongue, laryngeal and epiglottic movements, therapy might consist of strength and endurance exercises, the use of Vital Stim

Related Courses

Bolus Management Intervention in Pediatric Feeding Disorders
Presented by Jennifer Dahms, M.S., CCC-SLP, BCS-S
Video

Presenter

Jennifer Dahms, M.S., CCC-SLP, BCS-S
Course: #6185 1 Hour
  'Clear explanations of assessment and treatment techniques'   Read Reviews
Bolus management is critical for managing semi-solids and solid foods during meals. There are many types of bolus management issues that can impact safe and efficient feeding. It is critical that feeding therapists be able to identify the functional limitations in bolus management and understand which particular techniques will be beneficial for remediation.

Please note: This course is also offered in a series of titled "Improving Oral-Motor Functioning in Pediatric Feeding Disorders", course 6240, which is offered for .6 CEUs. By completing this course, you will NOT be eligible to complete course 6240 for credit.


Medicare Muscle: Creating Defensible Documentation
Presented by Lorelei O'Hara, M.A., CCC-SLP
Video

Presenter

Lorelei O'Hara, M.A., CCC-SLP
Course: #6346 1 Hour
  'Concise information presented in a format that was easy to understand'   Read Reviews
As claim scrutiny increases, it becomes critical that rehab professionals understand Centers for Medicare & Medicaid Services (CMS) requirements, and how to craft content that shows how our services met those requirements. This course will teach the requirements for services to be reimbursable by Medicare, as well as how to present SLP services through quality documentation.

Pharmacology and Swallowing - Part 1
Presented by Denise Dougherty, M.A., SLP
Video

Presenter

Denise Dougherty, M.A., SLP
Course: #6502 1 Hour
  'THE PRESENTER'S KNOWLEDGE WAS IMPRESSIVE'   Read Reviews
Medications can contribute to/exacerbate a patient’s dysphagia. This course will discuss the absorption and metabolism of medications, intended and unintended impact of medications, physiologic changes in the older adult and possible interactions that may occur with drugs, herbs and foods. A list of resources will be provided. (Part 2 - Course #6623)

Pharmacology and Swallowing - Part 2
Presented by Denise Dougherty, M.A., SLP
Video

Presenter

Denise Dougherty, M.A., SLP
Course: #6569 1 Hour
  'again THE INSTRUCTOR WAS WELL INFORMED AND SHARED HER KNOWLEDGE IN A STYLE THAT WAS USABLE AND UNDERSTANDIBLE'   Read Reviews
Medications can contribute to/exacerbate a patient’s dysphagia. This course will discuss meds and the phases of the swallow; physiologic changes in the older adult; possible interactions that may occur with drugs, herbs and foods; and impact of meds on taste/smell. Medications can also create a chronic cough and increased secretions, which may be mistaken as a dysphagia. A list of resources will be provided. (Part 1 - Course #6608)

Report Writing in Pediatric Feeding Disorders
Presented by Jennifer Dahms, M.S., CCC-SLP, BCS-S
Video

Presenter

Jennifer Dahms, M.S., CCC-SLP, BCS-S
Course: #6247 1 Hour
  'Presenter was informative and easy to listen to'   Read Reviews
In a world of reduced third party payments for feeding and dysphagia therapy, it is crucial that feeding therapists are able to convey the functional limitations in regards to a feeding disorder. It is important that goals truly be measurable and objective, but it is also important to connect those goals to how a child’s every-day functioning is affected by such deficits.

Please note: This course is also offered in a series titled "Improving Oral-Motor Functioning in Pediatric Feeding Disorders", course 6240, which is offered for .6 CEUs. By completing this course, you will NOT be eligible to complete course 6240 for credit.